Changes in Salivary amylase and glucose in diabetes : a scoping review
NAGIOS: RODERIC FUNCIONANDO

Changes in Salivary amylase and glucose in diabetes : a scoping review

DSpace Repository

Changes in Salivary amylase and glucose in diabetes : a scoping review

Show simple item record

dc.contributor.author Pérez Ros, Pilar
dc.contributor.author Navarro Flores, Emmanuel
dc.contributor.author Julián Rochina, Iván
dc.contributor.author Martínez Arnau, Francisco Miguel
dc.contributor.author Cauli, Omar
dc.date.accessioned 2021-03-12T15:55:59Z
dc.date.available 2021-03-12T15:55:59Z
dc.date.issued 2021
dc.identifier.uri https://hdl.handle.net/10550/78286
dc.description.abstract Background and Objective: Diabetes mellitus (DM) is a common long-term disease which can be related with salivary amylase levels. DM has recently been associated with salivary amylase diagnostics that could further impair diagnoses in the diabetic population, as well as being an interesting alternative to traditional methods of determine glucose levels. The main advantage of this method is related to the fact that it is a fast diagnostic method. The DM population experiences changes to their metabolism which affects their salivary parameters, making this an alternative procedure for diagnosis and follow-up of the illness due to the non-invasive nature of salivary analyzes. The objective of this review is to summarize the evidence regarding the changes in salivary amylase and glucose levels, and their relationship with blood markers of glycemic control used in clinical settings such as blood glucose and glycated hemoglobin. The differences in salivary amylase levels depending on the method of saliva collection under fasting or non-fasting conditions. The changes in salivary amylase depends on the type of diabetes, the type of insulin treatment or the quality of glycemic control. Conclusions: Salivary amylase concentration is increased in diabetic patients in most of the studies and salivary glucose concentration in all studies in both fasting and non-fasting (post-prandial) conditions. Salivary amylase and glucose concentration represent potential non-invasive biomarkers to evaluate glycemic control and clinical management of diabetic patients, although it is necessary to evaluate the influence of potential modulating factors such as age, duration diseases, sex and the effects of pharmacological treatments in these outcomes which remained to be elucidated.
dc.language.iso eng
dc.relation.ispartof Diagnostics, 2021, vol. 11, num. 3
dc.rights.uri info:eu-repo/semantics/openAccess
dc.source Pérez Ros, Pilar Navarro Flores, Emmanuel Julián Rochina, Iván Martínez Arnau, Francisco Miguel Cauli, Omar 2021 Changes in Salivary amylase and glucose in diabetes : a scoping review Diagnostics 11 3
dc.subject Diabetis
dc.title Changes in Salivary amylase and glucose in diabetes : a scoping review
dc.type info:eu-repo/semantics/article
dc.date.updated 2021-03-12T15:55:59Z
dc.identifier.doi https://doi.org/10.3390/diagnostics11030453
dc.identifier.idgrec 143948

View       (503.3Kb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics